In 2023, the leukemia mortality rate for men in the US stood at an estimated 8.3 deaths per 100,000 men. Forecast data from 2024 to 2028 suggest a stagnation in mortality rates at 8.3, indicating no year-on-year percentage changes. This flat trend results in a Compound Annual Growth Rate (CAGR) of 0% over five years, demonstrating no average annual variation in the forecast period.

Future trends to watch for include:

Developments in leukemia treatment innovations and increased access to healthcare potentially influencing mortality rates.
Demographic shifts, such as an aging population, which may impact leukemia incidence and mortality.
Impact of lifestyle and environmental factors on leukemia prevalence.